INAHTA Board Director (2018-2020)
Dr. Mouna Jameleddine is head of the HTA department at INEAS (Tunisian Authority of Assessment and Accreditation in Healthcare), of which she is a founding member. She is in charge of implementing HTA activities, aiming to provide healthcare decision-makers with evidence-based information about the added benefit and cost effectiveness of health technologies. She has led the elaboration of the first HTA report in Tunisia, intending to advise the national insurance company and is currently focusing on HTA processes and methodological guides.
With more than 10 years of professional experience in public health, Dr. Jameleddine started her career as a hospital pharmacist and joined INEAS in 2014. During that year, she also worked at the Minister of Health’s office where she collaborated on defining pharmaceuticals’ policies, besides carrying out several studies for national projects.
She has presented several communications at international HTA conferences and participated in various capacity building activities in many countries, aspiring to raise awareness on HTA. She acts as reviewer of manuscripts for scientific journals and participates in the elaboration of international HTA papers and guidebooks.
Holder of a doctorate in pharmacy, Ms. Jameleddine followed a Master of Science Program in «Drug development » at the Faculty of Pharmacy of Monastir. She graduated in « Pharmacoeconomics of drugs and medical devices » at the Paris Descartes University, where she also obtained EMAUD, the European Market Access University Diploma.